Clinical trial
Prospective, Randomized Controlled Trial Comparing High Dose Amoxicillin Versus Tetracycline Based Quadruple Therapy as Second-line Treatment for Resistant Helicobacter Pylori Infection
NCT02175927 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized Controlled Trial Comparing High Dose Amoxicillin Versus Tetracycline Based Quadruple Therapy as Second-line Treatment for Resistant Helicobacter Pylori Infection
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- October 31, 2015
- Enrollment
- 312 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori treatment failure